Neurodegenerative disease is an umbrella term for a range of conditions which primarily affect the neurons in the human brain.
Neurons are the building blocks of the nervous system, which includes the brain and spinal cord. Neurons normally don’t reproduce or replace themselves, so when they become damaged or die they cannot be replaced by the body. Examples of neurodegenerative diseases include Parkinson’s, Alzheimer’s, and Huntington’s disease.
Neurodegenerative diseases are incurable and debilitating conditions that result in progressive degeneration and / or death of nerve cells. This causes problems with movement (called ataxias), or mental functioning (called dementias).
Dementias are responsible for the greatest burden of neurodegenerative diseases, with Alzheimer’s representing approximately 60-70% of dementia cases.
The neurodegenerative diseases that RAVCARE focuses on are:
- Alzheimer’s disease (AD) and other dementias
- Parkinson’s disease (PD) and PD-related disorders
- Prion disease
- Motor neurone diseases (MND)
- Huntington’s disease (HD)
- Spinocerebellar ataxia (SCA)
- Spinal muscular atrophy (SMA)
.
RAVCARE Digital Therapeutics for Neurodegenerative Disease
The advent of digital therapeutics such as RAVCARE signifies a transformative shift in the management of neurodegenerative diseases.
The Transformative Power of Digital Therapeutics in Dementia Care
As the field of digital therapeutics continues to evolve, the future of dementia care holds immense promise.
How Effective are RAVCARE’s Digital Therapeutics in Managing Neurodegenerative Diseases
RAVCARE’s digital therapeutics have been designed to provide a comprehensive and personalized approach to managing neurodegenerative diseases. By leveraging cutting-edge technology and evidence-based interventions, the platform empowers individuals to take charge of their brain health and live a fuller, more independent life.
English 
Italiano 
Deutsch 
Français de Belgique 
Français 
Nederlands (België) 
Bahasa Indonesia 
Հայերեն 
العربية 
Español